Treatment of primary amyloidosis

Factors influencing equine embryo outcomes in OPU‑ICSI systems: Insights from a large‑scale program in Brazil.

Journal of equine veterinary science·2026

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

European journal of neurology·2020

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Journal of hematology & oncology·2018

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Leukemia·2016

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Leukemia·2016

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

Leukemia·2014

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.

Seminars in hematology·2026

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

Journal of diabetes investigation·2026

Conserved gammaherpesvirus protein kinase counters myeloid cell-specific type I IFN receptor but not IRF-3 expression to promote the establishment of chronic latent infection in the spleen.

Journal of virology·2026

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

Arthritis & rheumatology (Hoboken, N.J.)·2026

The association between psoriasis and body mass index: an observational retrospective study of 184 patients.

Folia medica·2026

Increased interleukin-6 and hepcidin-25 are associated with restless legs syndrome in rheumatoid arthritis patients.

Folia medica·2026

Sporadic inclusion body myositis: overreliance on histology may lead to misdiagnosis.

Folia medica·2026

Related Experiment Videos

Treatment of primary amyloidosis

Related Concept Videos

Factors influencing equine embryo outcomes in OPU‑ICSI systems: Insights from a large‑scale program in Brazil.

Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.

Pain in SCD-Many mechanisms and mysteries.

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.

Conserved gammaherpesvirus protein kinase counters myeloid cell-specific type I IFN receptor but not IRF-3 expression to promote the establishment of chronic latent infection in the spleen.

Persistent IL-18 fuels expansion of CD38+HLA-DR+CD8+ T cells in Still's disease and macrophage activation syndrome.

The association between psoriasis and body mass index: an observational retrospective study of 184 patients.

Increased interleukin-6 and hepcidin-25 are associated with restless legs syndrome in rheumatoid arthritis patients.

Sporadic inclusion body myositis: overreliance on histology may lead to misdiagnosis.

Related Experiment Videos

Treatment of primary amyloidosis

Related Concept Videos

Related Articles